The stereo structure of piperidine lactone (3), an intermediate of the antimalarial agent febrifugine ((؉)-1) prepared by a synthetic method, was re-revised to the cis-form from the transform.
Febrifugine ((ϩ)-1) and isofebrifugine ((ϩ)-2) are antimalarial agents that were isolated from Dichroa febrifuga and Hydrangea umbellate, respectively ( Fig. 1) . [1] [2] [3] [4] The plane structure 5) of (ϩ)-1 and (ϩ)-2 was first proposed in 1950. Subsequently, their relative 6) and absolute 7) structures were proposed, based on Baker's synthetic work. [8] [9] [10] The relative configuration 11) of (ϩ)-1 was corrected in 1973 and then the absolute structures 12, 13) of (ϩ)-1 and (ϩ)-2 were corrected in 1999. Currently, dramatic medical [14] [15] [16] [17] and synthetic [18] [19] [20] [21] [22] [23] [24] [25] studies of (ϩ)-1 are in progress. Historically, Barringer et al. 11) corrected the configuration of febrifugine to the trans-form from the cis-form in 1973, based on the 1 H-NMR data of an intermediate, piperidine lactone (3), which Baker et al. synthesized. 9) Each proton on the bridge-head of 3 was observed at d 4.69 and 5.15 ppm with a coupling constant of 8.5 Hz (Table 2) . Recently, Kobayashi et al. synthesized dimethyl derivatives of trans-3 in which each proton on the bridge-head was observed at d 3.09 and 4.09 ppm with a coupling constant of 10.4 Hz. 26, 27) From these directly opposing results, we thought that the structure of 3 could not be determined from the coupling constant.
In a molecular calculation, cis-3 afforded two optimized conformers with similar heats of formation, but differing chair (cis-3a) and boat (cis-3b) forms of the piperidine ring (Table 1 ). The dihedral angle between H 3a -C 3a -C 7a -H 7a involving the bridge-head protons of cis-3b was smaller than in cis-3a. These results showed that even if the configuration of 3 was cis, the coupling constant between H 3a -H 7a would reasonably be 8.5 Hz. Since this result strongly supports our hypothesis, we discuss the exact structure of 3 synthesized by Baker et al. and corrected by Barringer et al. cis-Piperidine lactone (cis-3), an intermediate of (Ϯ)-isofebrifugine (Ϯ-2), was prepared from cis-2-allyl-3-hydroxypiperidine derivatives (4) using our previously reported method 18, 19) (Chart 1). Ozonolysis of 4, followed by PCC oxidation afforded cis-piperidine lactone (cis-5) with a cbz group. Hydrogenolysis and benzoylation of cis-5 gave cis-3, which has the same 1 H-NMR spectrum as reported by Barringer et al. 11) Each proton on the bridge-head of cis-3 in the 1 H-NMR (60 MHz) spectrum was observed at d 4.69 and 5.15 ppm, with a coupling constant of 7.7 Hz ( Table 2 ).
The configuration of piperidine lactone (3) synthesized by Baker et al. is cis based on the spectrum data. However, the difference in the melting points of 3 and cis-3 was large. Consequently, we attempted to synthesis trans-3 (Chart 2). Considering green chemistry, the key intermediate, piperidine-2,3-diol (8), was prepared by our new method using oxidation of 2,3-dehydropiperidine (7) with Oxone ® instead of osmium reagent. N-Cbz-protected piperidine lactone (5) was prepared from 8 according to Kobayashi's method. 26, 27) As they discussed, the reaction of 9 with non-substituted ketene silyl acetal has low diastereoselectivity. Deprotection followed by benzoylation of 5 afforded a separable mixture (3 : 4) of trans-3 and cis-3.
The melting point and 1 H-NMR data of 3 reported by Barringer et al., cis-3, and trans-3 are summarized in Table 2 . It is clear that 3 is cis-3, since the difference in the melting points of 3 and trans-3 was larger than that between 3 and cis-3. Moreover, Burgess et al., who reported another method of synthesizing febrifugine in 1996, used Barringer's result to determine the syn or anti configuration of a derivative of 4 prepared by the reaction of piperidine oxide with allyl silane. 28) This result should also be corrected. Now, we know that the configuration of substituents on the piperidine ring in febrifugine is trans, without a doubt. Therefore, our result suggests that the isomerization of the cis-form to the trans-form occurs in the synthetic stage after 3 in Baker's synthesis of febrifugine. We are now in the process of determining at which stage in Baker's synthesis of febrifugine the isomerization occurs.
